The Iceland-based generic pharmaceuticals company, Actavis, announced last week that it has entered into a binding letter of intent with QRxPharma to launch MoxDuo® IR
Tag: Actavis
Pharmaceutical packaging company acquired by Actavis
Pharmaceutical packaging company PharmaPack has recently been acquired by international generic pharmaceuticals company Actavis for an undisclosed amount. Actavis recently bought 100 percent of the
Pharmaceuticals from Actavis for Japan earthquake relief delivered in record time
According to reports, generic pharmaceuticals manufacturer Actavis was able to deliver 10 million Levothyroxine tablets to Japan to aid the short supply Levothyroxine tablets after
Generic Atorvastatin delivered to Spain by Actavis’ sales division, Medis
The Iceland based generic pharmaceutical company, Actavis, recently announced that its third-party sales division, Medis, has delivered around 30 million tablets of Atorvastatin to its
Pantoprazole from Actavis launched on patent expiry in Germany, Ireland, Netherlands
Actavis Group, the international generic pharmaceuticals company, launched Pantoprazole tablets in Germany, Ireland, and the Netherlands as the patent expired on 6 May. This is
Actavis reintroduces Oxycodone in the US
Little Falls facility resumes production with FDA approval of critical pain solution Reykjavik, Iceland, 17 April 2009 — Actavis Group, the international generic pharmaceuticals company,
Fluvastatin SR from Actavis first to market in UK, Holland
Actavis Group, the international generic pharmaceuticals company, today announced the launch of Fluvastatin SR in the UK and the Netherlands. Actavis was first to market
Actavis and ASKA to create new generic pharmaceutical firm in Japan
Actavis Group and Japan’s ASKA Pharmaceutical formally signed contracts recently establishing a new joint company called Actavis ASKA K.K. The new business will be headquartered
Actavis starts its business in Ireland
Entering the Irish market last week, Actavis plans to create up to 25 new local jobs over the next five years and to launch more
Actavis launches Gemcitabine on patent expiry in EU markets
The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone
Clamelle of Actavis awarded in the UK
At the annual SMaRT Awards last week in Birmingham, UK, Actavis were triumphant, winning Best POM to P Switch of the Year Award for Clamelle.
